Orphazyme CFO to take up CEO mantle ahead of time
Anders Vadsholt, the current CFO of biotech company Orphazyme, will become the company’s CEO on Tuesday, one month earlier than previously announced.
by CHRISTOPHER DUE KARLSSON, translated by daniel pedersen
From Tuesday, biotech company Orphazyme’s current CFO, Anders Vadsholt, will be the company’s CEO.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Orphazyme predicts EU rejection after meeting with CHMP
For subscribers
